Insight Report 6 minutes Premium

What the Ozempic Economy Means for US Retail

What's Inside

Ozempic, a medication used to treat type 2 diabetes, is gaining strong momentum in the pharmaceutical market due to its ability to manage blood sugar levels and promote weight loss. The increased adoption of Ozempic and other drugs in the GLP-1 drug class reflects a broader consumer shift toward prioritizing health and wellness.

We dive into the implications of widespread GLP-1 drug use on US retail, including the impacts on sectors such as grocery and apparel.

Companies mentioned in this report include: Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, Walmart

Other relevant research:

This report is for paying subscribers only. Already a paying subscriber? Please log in to see the entire report.
If you wish to learn more about our subscription plans and become a paying subscriber, click here.